Pathway
|
Proteins Involved in Stem Cell Exhaustion in Aging
|
|
Apoptosis of Cochlear Hair Cells (Noise-Induced, Mouse Model)
|
|
mTOR Signaling
|
|
Telomer Attrition Triggers Genomic Instability
|
|
Leptin and CCK8 Activate Nodose Ganglia Neuron
|
|
P-cell Activation
|
|
I-cell: CCK-8 Secretion and Regulation of Eating Behavior
|
|
N-cell: Neurotensin Production
|
|
Serotonin Receptors Signaling
|
|
PRL and CSH Action in Mammary Gland
|
|
Thrombopoietin Receptors Signaling in Platelet Maturation
|
|
T-Cell Maturation (Hypothesis)
|
|
AHR Signaling in Th17 Cells Function
|
|
Th17-Cell Differentiation
|
|
AHR Signaling in Tr1 Cells Function
|
|
CXC Chemokine Receptor Signaling
|
|
CC Chemokine Receptor Signaling
|
|
Plasmin Effects in Inflammation
|
|
Proplatelet Maturation
|
|
AHR in Intestinal Cell Antimicrobial Barrier Maintenance
|
|
Basophil Activation
|
|
Eosinophil Survival by Cytokine Signaling
|
|
Mast-Cell Activation via IgE Signaling
|
|
Mast-Cell Activation without Degranulation through CXCR4 Signaling
|
|
Mast-Cell Activation without Degranulation
|
|
Macrophage M1 Lineage
|
|
CD16/CD14 Proinflammatory Monocyte Activation
|
|
anti-Inflammatory Function of Macrophage M2 Lineage
|
|
Neutrophil Recruitment and Priming
|
|
Negative Acute Phase Proteins Synthesis
|
|
Positive Acute Phase Proteins Synthesis
|
|
Vascular Endothelial Cell Activation by Cytokines
|
|
Vascular Endothelial Cell Activation by Blood Coagulation Factors
|
|
Adipokines Production by Adipocyte
|
|
Nociception Expression Targets Signaling
|
|
CCR1 Expression Targets
|
|
ADRA1A -> IL6 Production
|
|
PTGER2/3 -> Inflammation-Related Expression Targets
|
|
IL6 Expression Targets -> Nociception
|
|
Leptin -> CD25/IL6/IL10 Production
|
|
CHRNA7 -> IL8 Production
|
|
Proteins Involved in Atherosclerosis
|
|
Proteins Involved in Dilated Cardiomyopathy
|
|
Cardiomyocyte Hypertrophy
|
|
Hypertrophic Cardiomyopathy
|
|
Proteins Involved in Arterial Hypertension
|
|
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)
|
|
Proteins Involved in Pulmonary Hypertension
|
|
Endothelial Cell Dysfunction in Pulmonary Hypertension
|
|
Proteins Involved in Myocardial Ischemia
|
|
Preconditioning Ischemia
|
|
Lymphocyte Mediated Myocardial Injury in Myocarditis
|
|
Proteins Involved in Myocarditis
|
|
SOCS in Negative Feedback Regulation in Myocarditis
|
|
Hair Follicle Keratinocyte Apoptosis
|
|
Proteins Involved in Atopic Dermatitis
|
|
Melanoma
|
|
Apoptosis Block in Melanoma Cell
|
|
Proteins Involved in Melanoma
|
|
Proteins Involved in Psoriasis
|
|
T-Cells Differentiation Block in Psoriasis
|
|
IFN-gamma/TNF-alpha Mediated Cell Proliferation in Psoriasis
|
|
IL22 Induces Keratinocyte Proliferation in Psoriasis
|
|
Proteins with Altered Expression in Psoriasis
|
|
Th17-Cell Function in Systemic Lupus Erythematosus
|
|
Vitiligo
|
|
T-Cell Cytotoxic Response against Melanocytes in Vitiligo
|
|
Toll-like Receptors in beta-Cell
|
|
Donohue Syndrome Progression (Hypothesis)
|
|
Tubular Cell Dysfunction in Progressive Diabetic Nephropathy
|
|
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy
|
|
Podocyte Dysfunction in Diabetic Nephropathy
|
|
Proteins Involved in Diabetic Nephropathy
|
|
Proliferative Diabetic Retinopathy
|
|
Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles
|
|
Proteins Involved in Insulin Resistance
|
|
Insulin Resistance in Myocytes Induced by Obesity
|
|
Adiponectin Synthesis Declines in Insulin Resistance
|
|
Insulin Resistance in Hepatocytes
|
|
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease
|
|
Proteins Involved in non-Alcoholic Fatty Liver Disease
|
|
Oxidation of Fatty Acid in non-Alcoholic Fatty Liver Disease
|
|
Leptin in Insulin Synthesis and Secretion
|
|
FOXO1 and SREBP-1C Role in beta-Cell Suppression (Rodent Model)
|
|
Hashimoto's Thyroiditis
|
|
RET1 Mutation in Hyperparathyroidism
|
|
Thyroid Hormones in Adipose Tissue Metabolism
|
|
Thyroid Dysfunction
|
|
Graves Ophthalmopathy
|
|
KISS1 Production Impairment in Hypogonadotropic hypogonadism
|
|
Thyroid Stimulating Hormone (TSH) Resistance in Congenital Hypothyroidism
|
|
Overt Hypothyroidism, Primary
|
|
Thyrotropin Releasing Hormone (TRH) Hypothalamic Release in non-Autoimmune Hypothyroidism
|
|
Central Hypothyroidism
|
|
Tertiary Hypothyroidism
|
|
SOCS3 and PTPN1 in Hypothalamic Neuron Insensitivity to Insulin and Leptin
|
|
Adipokines Production by Adipocyte Impaired in Obesity
|
|
Proteins Involved in Obesity
|
|
CD4+T-Cell Response in Celiac Disease
|
|
Proteins Involved in Colorectal Neoplasms
|
|
Cetuximab Resistance in Colorectal Cancer
|
|
Metastatic Colorectal Cancer
|
|
EGFR Nuclear Signaling in Colorectal Cancer
|
|
Crohn's Disease
|
|
Paneth-Cell Function in Crohn's Disease
|
|
Th17-Cell Activation in Crohn's Disease
|
|
Proteins Involved in Inflammatory Bowel Diseases
|
|
Peutz-Jeghers Syndrome
|
|
Nicotine anti-Inflammatory Effect in Ulcerative Colitis
|
|
Proteins Involved in Ulcerative Colitis
|
|
Apoptosis Block in Acute Myeloid Leukemia Cell
|
|
RARA Signaling in Acute Myeloid Leukemia (M3)
|
|
Acute Myeloid Leukemia
|
|
B-Cell Acute Lymphoblastic Leukemia
|
|
Chronic Myeloid Leukemia
|
|
Diffuse Large-B-Cell Lymphoma
|
|
Diffuse Large-B-Cell Lymphoma ABC Subtype
|
|
Proteins Involved in Diffuse Large-B-Cell Lymphoma
|
|
Follicular Lymphoma
|
|
Proteins Involved in Hodgkin Lymphoma
|
|
Proteins Involved in Mantle Cell Lymphoma
|
|
Mantle Cell Lymphoma
|
|
IL6/IGF1/VEGFA Signaling in Multiple Myeloma
|
|
Multiple Myeloma
|
|
Proteins Involved in Multiple Myeloma
|
|
T-Cell Acute Lymphoblastic Leukemia
|
|
Proteins Involved in Hepatocellular Carcinoma
|
|
Hepatocellular Carcinoma
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
Proteins Involved in Pancreatic Cancer
|
|
Pancreatic Ductal Carcinoma
|
|
Growth Factor Signaling in Pancreatic Neoplasms
|
|
TRPM7/8 in Pancreatic Adenocarcinoma
|
|
Eosinophil Survival in Asthma
|
|
Il17 Signaling Related Neutrophilia in Asthma
|
|
TSLP Signaling in Bronchial Epithelial Cell in Asthma
|
|
Airway Smooth Muscle Cell High Rate Proliferation
|
|
IgE Induces Airway Smooth Muscle Cell Proliferation
|
|
Goblet-Cell Related Mucus Secretion in Asthma
|
|
Basophil Activation in Asthma
|
|
Mast-Cell Activation in Asthma
|
|
Th17-Cell Differentiation in Asthma
|
|
Mucin Production in Goblet Airway Epithelial Cells
|
|
Osteoclast Activation in Gout
|
|
Neutrophil Recruitment in Sinovium in Gout
|
|
Dendritic Cell Dysfunction in Psoriatic Arthritis
|
|
Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis
|
|
Osteoclast Activation in Psoriatic Arthritis
|
|
Keratinocyte Activation in Psoriatic Arthritis
|
|
Proteins Involved in Psoriatic Arthritis
|
|
Synovial Fibroblast Proliferation in Rheumatoid Arthritis
|
|
Osteoclast Activation in Rheumatoid Arthritis
|
|
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma
|
|
Skin Fibrosis
|
|
Th17-Cell Numbers Reduction in HIV
|
|
Diabetes Induced Periodontitis
|
|
Cowden Syndrome
|
|
Gluten Impact on Neuronal System (Hypothesis)
|
|
beta-Casomorphins/Opioid Receptors Affect Brain Function (Hypothesis)
|
|
IL6 and Insulin Resistance in Muscular Dystrophies
|
|
IL6 Promotes Inflammation in Muscular Dystrophies
|
|
Bone Loss in Osteoporosis
|
|
Proteins with Altered Expression in Rheumatoid Arthritis
|
|
Proteins Involved in Epilepsy
|
|
BDNF Upregulation Triggered by Seizures
|
|
Glioblastoma, Primary
|
|
Proteins Involved in Glioblastoma
|
|
Glioblastoma, Secondary
|
|
Astrocytoma
|
|
Proteins Involved in Astrocytoma
|
|
Proteins Involved in Glioma
|
|
Glioma Stem Cell Program Activation
|
|
Neuroblastoma
|
|
ALK Associated Neuroblastoma
|
|
Proteins Involved in Parkinson's Disease
|
|
IL6/IL12 Signaling Activates Immune System in Multiple Sclerosis
|
|
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway
|
|
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway
|
|
ERBB/VEGFR/Akt Signaling in Breast Cancer
|
|
IGF1R/AKT Signaling in Breast Cancer
|
|
ESR1/ERBB Positive Luminal Breast Cancer
|
|
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway
|
|
Breast Cancer
|
|
ESR1 Signaling in Breast Cancer
|
|
Endometrial Cancer
|
|
Endometrioid Endometrial Cancer
|
|
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer
|
|
Proteins Involved in Endometriosis
|
|
Leptin Role in Endometriosis
|
|
Proteins Involved in High-Grade Serous Ovarian Carcinoma
|
|
Endometrioid Ovarian Carcinoma
|
|
Proteins Involved in Endometrioid Ovarian Carcinoma
|
|
Clear Cell Ovarian Carcinoma
|
|
Proteins Involved in Mucinous Ovarian Carcinoma
|
|
High-Grade Serous Ovarian Carcinoma
|
|
Low-Grade Serous Ovarian Carcinoma
|
|
Proteins Involved in Low-Grade Serous Ovarian Carcinoma
|
|
Ovarian Cancer
|
|
Proteins Involved in Clear Cell Ovarian Carcinoma
|
|
Mucinous Ovarian Carcinoma
|
|
MIF Role in Cholesteatoma
|
|
IL6/JAK/STAT3 Signaling in Cholesteatoma
|
|
Cholesteatoma
|
|
Prostate Cancer
|
|
Proteins Involved in Prostate Cancer
|
|
TLR3 Role in Retinal Pigment Epithelial Cell
|
|
IL10/STAT3 Signaling in M2 Macrophage and Retinal Angiogenesis
|
|
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death
|
|
Proteins Involved in Noise-Induced Hearing Loss
|
|
Cochlear Inflammation (Noise-Induced)
|
|
Alveolar Macrophage Negative Regulation Declined in COPD
|
|
Mucin Hyperproduction in Goblet and Mucous Cells
|
|
Polycystins Mutation Effects in Cystic Kidney Disease
|
|
Proteins Involved in Polycystic Kidney Disease
|
|
Proteins Involved in Glomerulonephritis
|
|
Endothelial Cell Dysfunction in Glomerulonephritis
|
|
Endothelial Cell Dysfunction in Pyelonephritis
|
|
ANGPT2 -> STAT Expression Targets
|
|
ANGPT1 -> STAT Expression Targets
|
|
AREG -> STAT Expression Targets
|
|
Noradrenaline/Gs Expression Targets
|
|
Noreadrenaline/Gq Expression Targets
|
|
Epinephrine/Gs Expression Targets
|
|
Serotonin/Gq Expression Targets
|
|
Epinephrine/Gq Expression Targets
|
|
BTC -> STAT Expression Targets
|
|
IFNG -> ARRB1/STAT1 Signaling
|
|
CD2 Expression Targets
|
|
CD22 -> STAT Expression Targets
|
|
CD8 -> NFATC Expression Targets
|
|
CD80 -> ATF/CREB/CREBBP Expression Targets
|
|
CD86 -> ATF/CREB/CREBBP Expression Targets
|
|
CLCF1 Expression Targets
|
|
CXCL12 Expression Targets
|
|
CCL3 Expression Targets
|
|
CCL3L1 Expression Target
|
|
CCL16 Expression Targets
|
|
CCL5 Expression Targets
|
|
CCL7 Expression Target
|
|
CCL7 Expression Targets
|
|
CCL8 Expression Targets
|
|
CCL15 Expression Targets
|
|
CCL2 Expression Targets
|
|
IL8 Expression Targets
|
|
CSF3 Expression Targets
|
|
CSF2 -> STAT Expression Targets
|
|
CNTF Expression Targets
|
|
Clozapine Induced Granulocytopenia
|
|
EGF -> STAT Expression Targets
|
|
EGFR/ERBB -> STAT Signaling
|
|
EREG -> STAT Expression Targets
|
|
Erythropoietin -> STAT Expression Targets
|
|
PECAM1 Expression Targets
|
|
FGF2 -> STAT Expression Targets
|
|
FGF10 -> STAT Expression Targets
|
|
FGF18 -> STAT Expression Targets
|
|
FGF1 -> STAT Expression Targets
|
|
FGF9 -> STAT Expression Targets
|
|
FGF8 -> STAT Expression Targets
|
|
FGFR1 -> STAT Signaling
|
|
FGFR3 -> STAT Signaling
|
|
GH2/GHR Expression Target
|
|
GH1/GHR -> STAT Expression Targets
|
|
CSH1/GHR Expression Targets
|
|
CSH1/PRLR Expression Targets
|
|
GH1/PRLR Expression Targets
|
|
HBEGF -> STAT Expression Targets
|
|
HGF -> STAT Expression Targets
|
|
HGFR -> STAT Signaling
|
|
TAM Receptor Signaling Activation in Cancer
|
|
Receptors and Adaptor Proteins Activated in Cancer
|
|
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling
|
|
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling
|
|
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis
|
|
IL23A and IL17A Provoke Cancer-Associated Inflammation
|
|
STAT3 Inhibits Maturation of Dendritic Cells and Facilitates Cancer Progression
|
|
STAT3 Facilitates the Function of Treg Cells and Cancer Progression
|
|
Proteins with Altered Expression in Tumor-Promoting Inflammation
|
|
N2 Neutrophils in Tumor-Promoting Inflammation and Tumor Progression
|
|
Apoptosis Block by Inhibitor of Apoptosis Proteins (IAPs) in Cancer
|
|
Proteins with Altered Expression in Cancer-Associated Resisting to Cell Death
|
|
Suppression of Caspase Activity in Cancer
|
|
Apoptosis Evasion in Cancer: Overview
|
|
TERT Activation in Cancer
|
|
Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality
|
|
VEGFA Dependent Angiogenesis in Cancer
|
|
VEGF Independent Angiogenesis in Cancer
|
|
Proteins with Altered Expression in Cancer Metastases
|
|
Epithelial to Mesenchymal Transition in Cancer: Overview
|
|
BSG (CD147) in Cancer Cells Motility, Invasion and Survival
|
|
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival
|
|
Skeletal Muscle Wasting in Cancer Cachexia
|
|
Myeloid Derived Suppressor Cells in Cancer Immune Escape
|
|
IDO1 in Cancer Immune Escape
|
|
CD46/CD55/CD59 Inhibit Complement Mediated Lysis of Cancer Cells
|
|
EZH2 Methyltransferase Role in Cancer
|
|
IGF2 -> STAT Expression Targets
|
|
IGF1 -> STAT Expression Targets
|
|
Insulin -> STAT Expression Targets
|
|
CD2 -> STAT Signaling
|
|
ICAM2 -> CTNNB/FOXO/STAT3 Signaling
|
|
PECAM -> STAT Signaling
|
|
InsulinR -> STAT Signaling
|
|
IGF1R -> STAT Signaling
|
|
Elevated Receptors -> Expression Targets in Skin
|
|
IFNLR1-> STAT/NFKB Signaling
|
|
IFNW1/IFNR Expression Target
|
|
IFNA1/IFNR Expression Targets
|
|
IFNB1/IFNR Expression Targets
|
|
IFNG/IFNR Expression Targets
|
|
IL22R -> STAT3 Signaling
|
|
IL31R -> STAT Signaling
|
|
IL15R -> STAT Signaling
|
|
IL1R -> STAT3 Signaling
|
|
IL10R -> STAT Signaling
|
|
IL13R -> STAT Signaling
|
|
IL3R -> STAT Signaling
|
|
IL27R -> STAT Signaling
|
|
IL7R -> STAT Signaling
|
|
IL9R -> STAT Signaling
|
|
IL5R -> STAT Signaling
|
|
IL11R -> STAT3 Signaling
|
|
IL6R -> STAT Signaling
|
|
IL2R -> STAT Signaling
|
|
IL12R -> STAT Signaling
|
|
IL23R -> STAT3/NF-kB Signaling
|
|
IL21R -> STAT Signaling
|
|
IL7 Expression Targets
|
|
IL13 Expression Targets
|
|
IL21 Expression Targets
|
|
IL15 Expression Targets
|
|
IL12B Expression Targets
|
|
IL3 Expression Targets
|
|
IL16 -> STAT Expression Targets
|
|
IL6 Expression Targets
|
|
IL10 Expression Targets
|
|
IL5 Expression Targets
|
|
IL22 Expression Targets
|
|
IL11 Expression Targets
|
|
IL9 Expression Targets
|
|
IL31 Expression Targets
|
|
IL2 Expression Targets
|
|
Leptin -> STAT Expression Targets
|
|
Morphine Expression Targets
|
|
NRG1 -> STAT Expression Targets
|
|
OSM/OSMR Expression Targets
|
|
PDGFC -> STAT Expression Target
|
|
PDGFD -> STAT Expression Targets
|
|
PDGF -> STAT Expression Targets
|
|
PDGFB -> STAT Expression Target
|
|
PDGFR -> STAT Signaling
|
|
CSF2 -> STAT Signaling
|
|
KIT -> STAT Signaling
|
|
GAST Expression Targets in GAST Expression Targets
|
|
POMC Expression Targets
|
|
CCL11 Expression Targets
|
|
AVP/Gq -> STAT Expression Targets
|
|
IFNA1/Gq Expression Targets
|
|
AVP/Gs -> STAT Expression Targets
|
|
AGT -> STAT Expression Targets
|
|
PRL/PRLR Expression Targets
|
|
PRL/GHR -> STAT Expression Targets
|
|
ProlactinR -> STAT Signaling
|
|
PDCD1 -> STAT Expression Targets
|
|
ALK -> STAT Signaling
|
|
AngiopoietinR -> STAT Signaling
|
|
EphrinR -> STAT Signaling
|
|
CSF1 -> STAT Expression Targets
|
|
MDK/PTN Expression Targets
|
|
KITLG -> STAT Expression Targets
|
|
EphrinR Expression Targets
|
|
EFNA1 -> STAT Expression Target
|
|
PAF Expression Targets
|
|
FOXO1 Signaling
|
|
BMPR2 Signaling
|
|
Ras-GAP Regulation Signaling
|
|
Estrogens/ESR1 non-Genomic Signaling
|
|
EGFR Signaling
|
|
TCR -> STAT Expression Targets
|
|
T-Cell Receptor -> STAT Signaling
|
|
TGFA -> STAT Expression Targets
|
|
LTA Expression Targets
|
|
CD40LG -> STAT Expression Targets
|
|
TNF -> STAT Expression Targets
|
|
TNFRSF5 -> STAT Signaling
|
|
TNFRSF1A -> STAT Signaling
|
|
Thrombopoietin -> STAT Expression Targets
|
|
IL1B -> PGE2 Expression Targets
|
|
IL1B Expression Targets
|
|
IL1A Expression Targets
|
|
VEGFA -> STAT Expression Targets
|
|
VEGFR -> STAT Signaling
|
|
PPAR Psoriasis
|
|
pprarg neg, uknown targets, ps-positive
|
|
prarg neg,ukn expres targets, ps-positive
|
|
PPARG negative targets
|
|
pparg expr target_regulators
|
|
Neighbors of disease exacerbation
|
|
Neighbors of tumor progression
|
|
Neighbors of cancer progression
|
|
Neighbors of inflammatory status
|
|
Neighbors of overall survival
|
|
Neighbors of disease severity
|
|
Neighbors of tumor size
|
|
Neighbors of lesion size
|
|
Neighbors of mortality
|
|
Neighbors of survival rate
|
|
Neighbors of infarct size
|
|
Neighbors of survival time
|
|
Neighbors of functional recovery
|
|
Neighbors of insulin sensitivity
|
|
Neighbors of bacterial load
|
|
Neighbors of cancer survival
|
|
Neighbors of graft survival
|
|
Neighbors of therapeutic efficacy
|
|
Neighbors of clinical stage
|
|
Neighbors of lethality
|
|
Neighbors of tumor regression
|
|
Neighbors of recurrence-free survival
|
|
Neighbors of disease-free survival
|
|
Neighbors of tumor response
|
|
Neighbors of macrophage count
|
|
Neighbors of long-term survival
|
|
Neighbors of treatment outcome
|
|
Neighbors of body weight
|
|
Neighbors of body weight gain
|
|
Neighbors of cardiovascular risk
|
|
Neighbors of microvessel density
|
|
Neighbors of tumor recurrence
|
|
Neighbors of tumor promotion
|
|
Neighbors of neutrophil count
|
|
Neighbors of glucose tolerance
|
|
Neighbors of morbidity
|
|
Neighbors of fibrosis progression
|
|
Neighbors of mortality rate
|
|
Neighbors of fat mass
|
|
Neighbors of exhaustion
|
|
Neighbors of adverse outcome
|
|
Neighbors of radioresistance
|
|
Neighbors of lesion area
|
|
Neighbors of cell density
|
|
Neighbors of cancer-specific survival
|
|
Neighbors of progression-free survival
|
|
Neighbors of apoptosis rate
|
|
Neighbors of early mortality
|
|
Neighbors of viral load
|
|
Neighbors of blood pressure
|
|
Neighbors of tumor grade
|
|
Neighbors of body mass index
|
|
Neighbors of vascular density
|
|
Neighbors of muscle mass
|
|
Neighbors of cancer risk
|
|
Neighbors of cancer incidence
|
|
Neighbors of tumor aggressiveness
|
|
Neighbors of systolic blood pressure
|
|
Neighbors of tumor resistance
|
|
Neighbors of blood glucose
|
|
Neighbors of ejection fraction
|
|
Neighbors of median survival
|
|
Neighbors of fasting plasma glucose
|
|
Neighbors of T-cell count
|
|
Neighbors of antimetastatic activity
|
|
Neighbors of energy expenditure
|
|
Neighbors of glucose level
|
|
Neighbors of vascular tone
|
|
Neighbors of radiosensitivity
|
|
Neighbors of breast cancer risk
|
|
Neighbors of proliferation index
|
|
Neighbors of cell permeability
|
|
Neighbors of infarct area
|
|
Neighbors of fertility
|
|
Neighbors of pathological response
|
|
Neighbors of lymphocyte count
|
|
Neighbors of skin thickness
|
|
Neighbors of metabolic response
|
|
Neighbors of insulin level
|
|
Neighbors of bone volume
|
|
Neighbors of fractional shortening
|
|
Neighbors of disease exacerbation
|
|
Neighbors of tumor progression
|
|
Neighbors of cancer progression
|
|
Neighbors of inflammatory status
|
|
Neighbors of overall survival
|
|
Neighbors of disease severity
|
|
Neighbors of tumor size
|
|
Neighbors of lesion size
|
|
Neighbors of mortality
|
|
Neighbors of survival rate
|
|
Neighbors of infarct size
|
|
Neighbors of survival time
|
|
Neighbors of functional recovery
|
|
Neighbors of insulin sensitivity
|
|
Neighbors of bacterial load
|
|
Neighbors of cancer survival
|
|
Neighbors of graft survival
|
|
Neighbors of therapeutic efficacy
|
|
Neighbors of clinical stage
|
|
Neighbors of lethality
|
|
Neighbors of tumor regression
|
|
Neighbors of recurrence-free survival
|
|
Neighbors of disease-free survival
|
|
Neighbors of tumor response
|
|
Neighbors of macrophage count
|
|
Neighbors of long-term survival
|
|
Neighbors of treatment outcome
|
|
Neighbors of body weight
|
|
Neighbors of body weight gain
|
|
Neighbors of cardiovascular risk
|
|
Neighbors of microvessel density
|
|
Neighbors of tumor recurrence
|
|
Neighbors of tumor promotion
|
|
Neighbors of neutrophil count
|
|
Neighbors of glucose tolerance
|
|
Neighbors of morbidity
|
|
Neighbors of fibrosis progression
|
|
Neighbors of mortality rate
|
|
Neighbors of fat mass
|
|
Neighbors of exhaustion
|
|
Neighbors of adverse outcome
|
|
Neighbors of radioresistance
|
|
Neighbors of lesion area
|
|
Neighbors of cell density
|
|
Neighbors of cancer-specific survival
|
|
Neighbors of progression-free survival
|
|
Neighbors of apoptosis rate
|
|
Neighbors of early mortality
|
|
Neighbors of viral load
|
|
Neighbors of blood pressure
|
|
Neighbors of tumor grade
|
|
Neighbors of body mass index
|
|
Neighbors of vascular density
|
|
Neighbors of muscle mass
|
|
Neighbors of cancer risk
|
|
Neighbors of cancer incidence
|
|
Neighbors of tumor aggressiveness
|
|
Neighbors of systolic blood pressure
|
|
Neighbors of tumor resistance
|
|
Neighbors of blood glucose
|
|
Neighbors of ejection fraction
|
|
Neighbors of median survival
|
|
Neighbors of fasting plasma glucose
|
|
Neighbors of T-cell count
|
|
Neighbors of antimetastatic activity
|
|
Neighbors of energy expenditure
|
|
Neighbors of glucose level
|
|
Neighbors of vascular tone
|
|
Neighbors of radiosensitivity
|
|
Neighbors of breast cancer risk
|
|
Neighbors of proliferation index
|
|
Neighbors of cell permeability
|
|
Neighbors of infarct area
|
|
Neighbors of fertility
|
|
Neighbors of pathological response
|
|
Neighbors of lymphocyte count
|
|
Neighbors of skin thickness
|
|
Neighbors of metabolic response
|
|
Neighbors of insulin level
|
|
Neighbors of bone volume
|
|
Neighbors of fractional shortening
|
|
Neighbors of cell development
|
|
Neighbors of immune response
|
|
Neighbors of cell population
|
|
Neighbors of T-cell development
|
|
Neighbors of inflammatory response
|
|
Neighbors of wound healing
|
|
Neighbors of angiogenesis
|
|
Neighbors of innate immune response
|
|
Neighbors of cell function
|
|
Neighbors of macrophage activation
|
|
Neighbors of cell formation
|
|
Neighbors of adaptive immune response
|
|
Neighbors of osteoclast development
|
|
Neighbors of epithelial to mesenchymal transition
|
|
Neighbors of immunity
|
|
Neighbors of cell proliferative response
|
|
Neighbors of chemotaxis
|
|
Neighbors of dendritic cell differentiation
|
|
Neighbors of cell survival
|
|
Neighbors of osteoclast differentiation
|
|
Neighbors of cell phenotype
|
|
Neighbors of T-cell proliferation
|
|
Neighbors of tissue remodeling
|
|
Neighbors of cell adhesion
|
|
Neighbors of T-cell activation
|
|
Neighbors of endothelial cell proliferation
|
|
Neighbors of fibrogenesis
|
|
Neighbors of tumor growth
|
|
Neighbors of dendritic cell development
|
|
Neighbors of tissue repair
|
|
Neighbors of cell count
|
|
Neighbors of cell infiltration
|
|
Neighbors of cell interaction
|
|
Neighbors of SMC proliferation
|
|
Neighbors of lumen formation
|
|
Neighbors of endothelial cell migration
|
|
Neighbors of adipogenesis
|
|
Neighbors of lipid storage
|
|
Neighbors of cell damage
|
|
Neighbors of pregnancy
|
|
Neighbors of monocyte differentiation
|
|
Neighbors of aging
|
|
Neighbors of cell motility
|
|
Neighbors of monocyte migration
|
|
Neighbors of fibroblast proliferation
|
|
Neighbors of adipocyte differentiation
|
|
Neighbors of macrophage migration
|
|
Neighbors of microglial activation
|
|
Neighbors of neutrophil recruitment
|
|
Neighbors of regeneration
|
|
Neighbors of cell migration
|
|
Neighbors of cancer growth
|
|
Neighbors of stem cell proliferation
|
|
Neighbors of smooth muscle cell migration
|
|
Neighbors of hepatic regeneration
|
|
Neighbors of transendothelial migration
|
|
Neighbors of phagocytosis
|
|
Neighbors of immune system activation
|
|
Neighbors of leukocyte recruitment
|
|
Neighbors of osteoclast formation
|
|
Neighbors of cell invasion
|
|
Neighbors of heart function
|
|
Neighbors of hemopoiesis
|
|
Neighbors of bone remodeling
|
|
Neighbors of ossification
|
|
Neighbors of T-cell function
|
|
Neighbors of immune system function
|
|
Neighbors of lung development
|
|
Neighbors of autophagy
|
|
Neighbors of monocyte adhesion
|
|
Neighbors of transcription activation
|
|
Neighbors of senescence
|
|
Neighbors of T-cell response
|
|
Neighbors of tumor immunity
|
|
Neighbors of hepatocyte proliferation
|
|
Neighbors of cell transdifferentiation
|
|
Neighbors of neuroprotection
|
|
Neighbors of stem cell differentiation
|
|
Neighbors of endothelial cell function
|
|
Neighbors of neuronal death
|
|
Neighbors of cell growth
|
|
Neighbors of ROS generation
|
|
Neighbors of epithelial cell proliferation
|
|
Neighbors of first trimester pregnancy
|
|
Neighbors of cancer cell growth
|
|
Neighbors of sensitization
|
|
Neighbors of hemato-encephalic barrier
|
|
Neighbors of macrophage function
|
|
Neighbors of cellular immune response
|
|
Neighbors of cellular senescence
|
|
Neighbors of colony formation
|
|
Neighbors of macrophage differentiation
|
|
Neighbors of cell differentiation
|
|
Neighbors of keratinocyte proliferation
|
|
Neighbors of stem cell migration
|
|
Neighbors of life span
|
|
Neighbors of cell homeostasis
|
|
Neighbors of psoriasis
|
|
Neighbors of inflammatory disease
|
|
Neighbors of rheumatoid arthritis
|
|
Neighbors of atherosclerosis
|
|
Neighbors of fibrosis
|
|
Neighbors of colitis
|
|
Neighbors of arthritis
|
|
Neighbors of inflammatory bowel disease
|
|
Neighbors of injury
|
|
Neighbors of atherogenesis
|
|
Neighbors of vascular remodeling
|
|
Neighbors of metastasis
|
|
Neighbors of carcinogenesis
|
|
Neighbors of multiple sclerosis
|
|
Neighbors of chronic inflammation
|
|
Neighbors of inflammation
|
|
Neighbors of tumor microenvironment
|
|
Neighbors of pathological angiogenesis
|
|
Neighbors of obesity
|
|
Neighbors of vascular disease
|
|
Neighbors of diabetes mellitus
|
|
Neighbors of asthma
|
|
Neighbors of pneumonia
|
|
Neighbors of hyperplasia
|
|
Neighbors of osteoarthritis
|
|
Neighbors of liver fibrosis
|
|
Neighbors of chronic obstructive pulmonary disease
|
|
Neighbors of myocardial infarction
|
|
Neighbors of leukocyte infiltration
|
|
Neighbors of reperfusion injury
|
|
Neighbors of airway inflammation
|
|
Neighbors of hepatitis
|
|
Neighbors of insulin resistance
|
|
Neighbors of infection
|
|
Neighbors of vascular injury
|
|
Neighbors of renal injury
|
|
Neighbors of preeclampsia
|
|
Neighbors of macrophage infiltration
|
|
Neighbors of liver injury
|
|
Neighbors of neuroinflammation
|
|
Neighbors of sepsis
|
|
Neighbors of death
|
|
Neighbors of type 1 diabetes
|
|
Neighbors of encephalomyelitis
|
|
Neighbors of autoimmune disease
|
|
Neighbors of ischemic stroke
|
|
Neighbors of dermatitis
|
|
Neighbors of neutrophil infiltration
|
|
Neighbors of heart disease
|
|
Neighbors of diabetic nephropathy
|
|
Neighbors of lung injury
|
|
Neighbors of immunopathology
|
|
Neighbors of systemic sclerosis
|
|
Neighbors of hepatocellular carcinoma
|
|
Neighbors of autoimmunity
|
|
Neighbors of acute lung injury
|
|
Neighbors of gastric cancer
|
|
Neighbors of experimental autoimmune encephalomyelitis
|
|
Neighbors of colorectal cancer
|
|
Neighbors of cardiac remodeling
|
|
Neighbors of breast cancer
|
|
Neighbors of ischemia
|
|
Neighbors of systemic lupus erythematosus
|
|
Neighbors of melanoma
|
|
Neighbors of collagen-induced arthritis
|
|
Neighbors of interstitial fibrosis
|
|
Neighbors of neoplasm invasion
|
|
Neighbors of kidney disease
|
|
Neighbors of heart failure
|
|
Neighbors of lung disease
|
|
Neighbors of pulmonary fibrosis
|
|
Neighbors of cardiovascular disease
|
|
Neighbors of stroke
|
|
Neighbors of cancer
|
|
Neighbors of cerebral ischemia
|
|
Neighbors of type 2 diabetes
|
|
Neighbors of neoplasm
|
|
Neighbors of endometriosis
|
|
Neighbors of neointima
|
|
Neighbors of vasculitis
|
|
Neighbors of atrophy
|
|
Neighbors of diet-induced obesity
|
|
Neighbors of respiratory hypersensitivity
|
|
Neighbors of myocardial fibrosis
|
|
Neighbors of synovitis
|
|
Neighbors of coronary artery disease
|
|
Neighbors of rupture
|
|
Neighbors of endothelial cell dysfunction
|
|
Neighbors of liver disease
|
|
Neighbors of prostate cancer
|
|
Neighbors of hypertrophy
|
|
Neighbors of osteolysis
|
|
Neighbors of ovarian cancer
|
|
Neighbors of pancreatic cancer
|
|
Neighbors of hypertension
|
|
Neighbors of intimal hyperplasia
|
|
Neighbors of proteinuria
|
|
Neighbors of epithelial cell
|
|
Neighbors of keratinocyte
|
|
Neighbors of monocyte
|
|
Neighbors of macrophage
|
|
Neighbors of intestine epithelium cell
|
|
Neighbors of hepatocyte
|
|
Neighbors of endothelial cell
|
|
Neighbors of dendritic cell
|
|
Neighbors of inflammatory cell
|
|
Neighbors of neutrophil
|
|
Neighbors of astrocyte
|
|
Neighbors of cardiac myocyte
|
|
Neighbors of myeloid cell
|
|
Neighbors of stem cell
|
|
Neighbors of leukocyte
|
|
Neighbors of insulin-secreting cell
|
|
Neighbors of T-cell
|
|
Neighbors of hematopoietic cell
|
|
Neighbors of podocyte
|
|
Neighbors of antigen-presenting cell
|
|
Neighbors of lung
|
|
Neighbors of liver
|
|
Neighbors of kidney
|
|
Neighbors of skin
|
|
Neighbors of intestine
|
|
Neighbors of lymph node
|
|
Neighbors of colon
|
|
Neighbors of blood vessel
|
|
Neighbors of heart
|
|
Neighbors of microvessel
|
|
Neighbors of uterus
|
|
Neighbors of esophagus
|
|
Neighbors of retina
|
|
Neighbors of brain
|
|
Neighbors of ovary
|
|
Neighbors of breast
|
|
Neighbors of blood vessel wall
|
|
Neighbors of stomach
|
|
Neighbors of artery
|
|
Neighbors of pancreas
|
|
Neighbors of prostate
|
|
Neighbors of decidua
|
|
Neighbors of immune system
|
|
Neighbors of vein
|
|
Neighbors of ankle joint
|
|
Neighbors of thymus gland
|
|
Neighbors of brain blood vessel
|
|
Neighbors of myelin sheath
|
|
Neighbors of blastocyst
|
|
Neighbors of nerve
|
|
Neighbors of NF-kB family
|
|
Neighbors of PPAR
|
|
Neighbors of PI3K
|
|
Neighbors of STAT family
|
|
Neighbors of mitogen-activated protein kinase
|
|
Neighbors of IFNAR ligand
|
|
Neighbors of cytokine
|
|
Neighbors of JAK
|
|
Neighbors of Ras GTPase
|
|
Neighbors of ERK1/2
|
|
Neighbors of ovalbumin
|
|
Neighbors of IgG
|
|
Neighbors of SMAD subfamily
|
|
Neighbors of estrogen receptor
|
|
Neighbors of Notch
|
|
Neighbors of heat shock protein 90
|
|
Neighbors of proteasome endopeptidase complex
|
|
Neighbors of non-coding RNA
|
|
Neighbors of STAT5
|
|
Neighbors of retinoid-X receptor subfamily
|
|
Neighbors of WNT
|
|
Neighbors of PP2B
|
|
Neighbors of TORC1
|
|
Neighbors of Rho kinase
|
|
Neighbors of PDGF receptor
|
|
Neighbors of caspase
|
|
comon ps_pos, pprarg_neg targets
|
|
Model of PPARG signaling in psoriasis
|
|
PPARG negative regulators and targets
|
|
Model of PPARG related pathways in psoriasis (short version)
|
|
New Pathway (5)
|
|
New Pathway (3)
|
|
sars-cov no binding
|
|
H2A-K119 and H3-K27
|
|
New Pathway
|
|
IFN signaling in alveolar cells
|
|
Possible Interplay between SOX11, CCND1 and EZH2 in Mantle Cell Lymphoma
|
|
Figure 3_Mixed network of dexamethasone targets
|
|
Figure 3_Mixed network of dexamethasone targets
|
|
1_Differentiation of psoriatic T cells
|
|
2_Interleukin-17 and interleukin-22 signaling in psoriasis
|
|
1_Formation of cysts in polycystic kidney disease
|
|
2_The role of endothelial cells in pyelonephritis
|
|
3_The role of interstitial fibroblasts in pyelonephritis
|
|
3_Mesangial cell dysfunction in glomerulonephritis
|
|
3_Role of neurotrophic factor deprivation in retinal ganglion cell death
|
|
1_Endothelial cells stimulate vasoconstriction and thrombosis in pulmonary hypertension
|
|
3_Increased proliferation of pulmonary artery smooth muscle cells (PASMCs) in familial forms of pulmonary hypertension
|
|
2_Cardiomyocyte hypertrophy
|
|
1_Th2 cell response in asthma
|
|
3_1_Mucus accumulation in asthma
|
|
2_2_Eosinophilia and neutrophilia in asthma: eosinophil apoptosis
|
|
4_Mucin hyperproduction in goblet and mucous cells in COPD
|
|
2_Paneth cell dysfunction in Crohn's disease
|
|
1_Defects in response to pathogens in the gut promotes inflammation in Crohn's disease
|
|
4_1_Polymorphisms associated with inflammatory bowel diseases
|
|
1_Inflammatory mediators increase the production of hepcidin (HAMP)
|
|
4_Inflammatory mediators inhibit GATA signaling in erythropoiesis
|
|
4_2_Insulin resistance: inflammation-related insulin resistance
|
|
4_3_Insulin resistance: FFA-related insulin resistance
|
|
1_Antigen-presenting cells promote islet dysfunction and immune system activation in T1D
|
|
2_Defective tolerance of autoreactive T-cell in T1D
|
|
1_Decreased secretion of thyroid hormones
|
|
Model of PPARG signaling in psoriais (tested)
|
|
before laser treatment
|
|
New Pathway
|
|
Differentiation of psoriatic T cells
|
|
Interleukin-17 and interleukin-22 signaling in psoriasis
|
|
Anti-psoriatic drugs influence PPARG signaling
|
|
PPARG signaling after laser treatment
|